Related Experiment Video

Updated: Nov 5, 2025

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

33.8K

The Heterogeneity Metabolism of Renal Cell Carcinomas

Mohammadreza Zarisfi1, Tu Nguyen2, Jessie R Nedrow1

  • 1Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Advances in Experimental Medicine and Biology
|May 20, 2021
PubMed

Insights

Renal cell carcinoma (RCC) is a deadly cancer. Understanding its diverse metabolic profiles is crucial for developing new treatments to improve patient survival and overcome treatment resistance.

Area of Science:

  • Oncology
  • Metabolic Research
  • Cancer Biology

Background:

  • Renal cell carcinoma (RCC) is a significant global health concern, causing over 100,000 deaths annually.
  • Cancer's resistance to standard therapies is often due to oncogenic heterogeneity, where gene expression and metabolic phenotypes vary widely.
  • Single-therapy approaches are insufficient due to this heterogeneity, necessitating novel treatment strategies.

Purpose of the Study:

  • To highlight the challenge of uncovering distinct metabolic profiles in RCC.
  • To emphasize the need for novel strategies targeting cancer metabolism.
  • To explore new perspectives in metabolic research for RCC treatment development.

Main Methods:

  • Review of current data on RCC and cancer metabolism.
  • Analysis of oncogenic heterogeneity as a factor in treatment resistance.
  • Exploration of metabolic research approaches for understanding cancer phenotypes.

Main Results:

  • Despite progress, a comprehensive understanding of RCC's distinct metabolic profiles remains a challenge.
  • Novel strategies targeting diverse cancer metabolism show promise but require further investigation.
  • Metabolic research offers new perspectives for developing more effective RCC treatments.

Conclusions:

  • Effective treatments for RCC must address oncogenic heterogeneity and diverse metabolic phenotypes.
  • Continued metabolic research is essential for uncovering RCC's metabolic profiles and advancing therapeutic development.
  • Targeting cancer metabolism holds significant potential for improving patient survival outcomes in RCC.
Keywords:
Glucose metabolismGlutamine metabolismMetabolic phenotypesOncogenic heterogeneity—intratumoral heterogeneityRenal cell carcinoma

More Related Videos

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression06:29

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression

Published on: January 31, 2025

935
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

13.9K

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
393
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
41
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
485
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
49
Renal Drug Excretion: Overview01:15

Renal Drug Excretion: Overview

As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
400